Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...